UNII UX6OWY2V7J

CODEINE ANHYDROUS

Unique Ingredient Identifier UX6OWY2V7J is listed as a ingredient substance
unii - Ux6owy2v7j"utf-8"/>
"__next">
FDA official logo
GSRS logo
PFDA official logo

CODEINE ANHYDROUS

  • UNII: UX6OWY2V7J
  • Formula: C18H21NO3
  • Preferred Substance Name: CODEINE ANHYDROUS
  • InChIKey: OROGSEYTTFOCAN-DNJOTXNNSA-N

  • 76-57-3
  • 200-969-1
  • 7,8-DIDEHYDRO-4,5.ALPHA.-EPOXY-3-METHOXY-17-METHYLMORPHINAN-6.ALPHA.-OL
  • BENZENE, DIETHENYL-, POLYMER WITH ETHENYLBENZENE, SULFONATED, COMPLEX WITH (5.ALPHA.,6.ALPHA.)-7,8-DIDEHYDRO-4,5-EPOXY-3-METHOXY-17-METHYLMORPHINAN-6-OL
  • BENZENE, DIETHENYL-, POLYMER WITH ETHENYLBENZENE, SULPHONATED, COMPLEX WITH (5.ALPHA.,6.ALPHA.)-7,8-DIDEHYDRO-4,5-EPOXY-3-METHOXY-17-METHYLMORPHINAN-6-OL
  • CODEINE [HSDB]
  • CODEINE [MI]
  • CODEINE [WHO-DD]
  • CODEINE POLISTIREX
  • CODEINE POLISTIREX [ORANGE BOOK]
  • CODEINE POLISTIREX [USAN]
  • CODEINE POLISTIREX [VANDF]
  • CODEINE POLISTIREX [WHO-DD]
  • CODEINE POLISTIREX COMPONENT OF CODEPREX
  • CODEINE POLISTIREX COMPONENT OF PENNTUSS
  • CODEPREX COMPONENT CODEINE POLISTIREX
  • CODICEPT
  • CODUCEPT
  • DIHYDROCODEINE HYDROGEN TARTRATE IMPURITY A [EP IMPURITY]
  • HYDROCODONE HYDROGEN TARTRATE 2.5-HYDRATE IMPURITY C [EP IMPURITY]
  • IDS-NC-005(SECT.-2)
  • KODELAK FITO
  • METHYLMORPHINE
  • MORPHINAN-6-OL, 7,8-DIDEHYDRO-4,5-EPOXY-3-METHOXY-17-METHYL-, (5.ALPHA.,6.ALPHA.)-
  • MORPHINE MONOMETHYL ETHER
  • MORPHINE SULFATE IMPURITY A [EP IMPURITY]
  • MYTUSSIN
  • O3-METHYLMORPHINE
  • PENNTUSS COMPONENT CODEINE POLISTIREX
  • SS85U8K5ZN
  • SULFONATED STYRENE-DIVINYLBENZENE COPOLYMER COMPLEX WITH 7,8-DIDEHYDRO-4,5.ALPHA.-EPOXY-3-METHOXY-17-METHYLMORPHINAN-6.ALPHA.-OL
  • SULPHONATED STYRENE-DIVINYLBENZENE COPOLYMER COMPLEX WITH 7,8-DIDEHYDRO-4,5.ALPHA.-EPOXY-3-METHOXY-17-METHYLMORPHINAN-6.ALPHA.-OL

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.